Maqola

The PRISMA 2020 statement: an updated guideline for reporting systematic reviews

Matthew J. PageSchool of Public Health and Preventive Medicine, Monash University, Melbourne, Australia [email protected]Joanne E. McKenzieSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaPatrick M. BossuytDepartment of Clinical Epidemiology, Biostatistics and Bioinformatics, Amsterdam University Medical Centres, University of Amsterdam, Amsterdam, NetherlandsIsabelle BoutronUniversité Paris CitéTammy HoffmannInstitute for Evidence-Based Healthcare, Faculty of Health Sciences and Medicine, Bond University, Gold Coast, AustraliaCynthia D. MulrowUniversity of Texas Health Science Center at San Antonio, San Antonio, Texas, USA; Annals of Internal MedicineLarissa ShamseerKnowledge Translation Program, Li Ka Shing Knowledge Institute, Toronto, CanadaJennifer TetzlaffElie A. AklClinical Research Institute, American University of Beirut, Beirut, LebanonSue BrennanSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaRoger ChouDepartment of Medical Informatics and Clinical Epidemiology, Oregon Health & Science University, Portland, Oregon, USAJulie GlanvilleUniversity of YorkJeremy GrimshawClinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, CanadaAsbjørn HróbjartssonCentre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark, Department of Clinical Research, University of Southern Denmark, Odense, DenmarkManoj M. LaluDepartment of Anesthesiology and Pain Medicine, The Ottawa Hospital, Ottawa, Canada; Clinical Epidemiology Program, Blueprint Translational Research Group, Ottawa Hospital Research Institute, Ottawa, Canada; Regenerative Medicine Program, Ottawa Hospital Research Institute, Ottawa, CanadaTianjing LiDepartment of Ophthalmology, School of Medicine, University of Colorado Denver, Denver, Colorado, United States; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USAElizabeth LoderDivision of Headache, Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USAEvan Mayo‐WilsonDepartment of Epidemiology and Biostatistics, Indiana University School of Public Health-Bloomington, Bloomington, Indiana, USASteve McDonaldSchool of Public Health and Preventive Medicine, Monash University, Melbourne, AustraliaLuke A. McGuinnessPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKLesley StewartCentre for Reviews and Dissemination, University of York, York, UKJames ThomasEPPI-Centre, UCL Social Research Institute, University College London, London, UKAndrea C. TriccoQueen's Collaboration for Health Care Quality Joanna Briggs Institute Centre of Excellence, Queen's University, Kingston, CanadaVivian WelchMethods Centre, Bruyère Research Institute, Ottawa, Ontario, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, CanadaPenny WhitingPopulation Health Sciences, Bristol Medical School, University of Bristol, Bristol, UKDavid MoherCentre for Journalology, Clinical Epidemiology Program, Ottawa Hospital Research Institute, Ottawa, Canada; School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, Canada

2021en

Ochiq kirishGibrid

Litsenziya: cc-by

ABI

Annotatsiya

The Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) statement, published in 2009, was designed to help systematic reviewers transparently report why the review was done, what the authors did, and what they found. Over the past decade, advances in systematic review methodology and terminology have necessitated an update to the guideline. The PRISMA 2020 statement replaces the 2009 statement and includes new reporting guidance that reflects advances in methods to identify, select, appraise, and synthesise studies. The structure and presentation of the items have been modified to facilitate implementation. In this article, we present the PRISMA 2020 27-item checklist, an expanded checklist that details reporting recommendations for each item, the PRISMA 2020 abstract checklist, and the revised flow diagrams for original and updated reviews.

Hali tarjima qilinmagan

Identifikatorlar

DOI: 10.1136/bmj.n71

Iqtiboslar va manbalar

98 ta iqtibos0 ta foydalanilgan manba